Sumitomo Mitsui Trust Holdings, Inc. Bridge Bio Pharma, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$11.38 - $53.41 $74,061 - $347,592	-6,508 Closed	0 $0
Q3 2021 Oct 25, 2021	SELL	$46.87 - $64.24 $8,483 - $11,627	-181 Reduced 2.71%	6,508 $305,000
Q2 2021 Aug 02, 2021	SELL	$46.47 - $63.93 $13,058 - $17,964	-281 Reduced 4.03%	6,689 $408,000
Q1 2021 Apr 30, 2021	SELL	$55.47 - $72.35 $36,499 - $47,606	-658 Reduced 8.63%	6,970 $429,000
Q4 2020 Feb 05, 2021	BUY	$38.38 - $71.11 $292,762 - $542,427	7,628 New	7,628 $542,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.